Home / Open for comment

PROPOSED RULECOMMENTS DUE JANUARY 19, 2027

Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition

Health and Human Services Department / Food and Drug Administration

The Food and Drug Administration (FDA or we) is proposing to issue a regulation finding that N-acetyl-L-cysteine (NAC) is not excluded from the dietary supplement definition in the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action, if finalized, would allow products containing NAC to be lawfully marketed as dietary supplements, provided that such products are not otherwise in violation of the FD&C Act. We also propose to provide that the addition of NAC to a dietary supplement is not a prohibited act under section 301(ll) of the FD&C Act.

Published November 17, 2026Document 2026-23351

How to comment

Comments are due January 19, 2027. Submit through the link above or follow the instructions in the document's ADDRESSES section. Say who you are, how the rule affects you, and what should change, with evidence. Comments are usually public, so leave out anything private.

New to this? Start with our free public-comment guide and example, watch Rulemaking 101 or read How to Comment on Federal Rules.

From the Federal Register as of November 20, 2026. Deadlines can change; the official document governs. Not legal advice.

Know someone following this?

Send them the page so they can check the source and the deadline.